Re- Appointment of M/s. Vas & Co., Chartered Accountants as Internal Auditors of the Company for Financial Year 2026-27
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.5 pts less than Nifty Microcap 250 and 4.9 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gayatri BioOrganics Limited reported a net loss of Rs 111.18 lakhs for FY 2025-26, worsening from Rs 72.65 lakhs loss in the prior year—a 53% increase in losses. The company has zero revenue from operations and relies on other income. The balance sheet shows negative equity of Rs 3,700.49 lakhs, indicating technical insolvency. Total assets stood at Rs 171.75 lakhs against borrowings of Rs 3,523.14 lakhs. The company has operating cash outflows of Rs 73.54 lakhs and contingent liabilities totaling approximately Rs 2,486 lakhs across multiple disputed tax matters. Statutory auditors MGR & Co. issued an unmodified opinion with an Emphasis of Matter on undisclosed notes. The board also appointed M/s. Vas & Co. as internal auditors for FY 2026-27. The financial statements are prepared on a going concern basis relying on promoter comfort letters.
The company's financial health is critically weak with negative equity, mounting losses, and no operational revenue. Shareholders face extreme risk as the company is technically insolvent with reliance on promoter support. The stock carries high speculative risk.